Correlation Between Tango Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Tango Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tango Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tango Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Tango Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tango Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tango Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Tango Therapeutics and Mineralys Therapeutics,
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tango and Mineralys is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Tango Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Tango Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tango Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Tango Therapeutics i.e., Tango Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Tango Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Tango Therapeutics is expected to generate 1.73 times more return on investment than Mineralys Therapeutics,. However, Tango Therapeutics is 1.73 times more volatile than Mineralys Therapeutics, Common. It trades about 0.0 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 731.00 in Tango Therapeutics on September 24, 2024 and sell it today you would lose (421.00) from holding Tango Therapeutics or give up 57.59% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 94.97% |
Values | Daily Returns |
Tango Therapeutics vs. Mineralys Therapeutics, Common
Performance |
Timeline |
Tango Therapeutics |
Mineralys Therapeutics, |
Tango Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tango Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Tango Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tango Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.Tango Therapeutics vs. Third Harmonic Bio | Tango Therapeutics vs. Cullinan Oncology LLC | Tango Therapeutics vs. Edgewise Therapeutics | Tango Therapeutics vs. Rallybio Corp |
Mineralys Therapeutics, vs. Fate Therapeutics | Mineralys Therapeutics, vs. Sana Biotechnology | Mineralys Therapeutics, vs. Caribou Biosciences | Mineralys Therapeutics, vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |